IBIO, INC. (IBIO) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 100.00K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $100.00K | (m) | (m) |
| 2026-03-31 | (m) | $300.00K | (m) | (m) |
| 2025-12-31 | (m) | $300.00K | (m) | (m) |
| 2025-09-30 | (m) | $500.00K | (m) | (m) |
| 2025-06-30 | (m) | $400.00K | (m) | (m) |
| 2025-03-31 | (m) | $375.00K | (m) | (m) |
| 2024-12-31 | (m) | $375.00K | (m) | (m) |
| 2024-09-30 | (m) | $175.00K | (m) | (m) |
| 2024-06-30 | (m) | $225.00K | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $50.00K | (m) | (m) |
| 2023-06-30 | (m) | $0.00 | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.00M | (m) | (m) |
| 2022-09-30 | (m) | $2.30M | (m) | (m) |
| 2022-06-30 | $2.17M | $2.38M | $216.00K | 90.94% |
| 2022-03-31 | $2.42M | $2.81M | $388.00K | 86.21% |
| 2021-12-31 | $338.00K | $1.64M | $1.30M | 20.67% |
| 2021-09-30 | $777.00K | $2.17M | $1.40M | 35.77% |
| 2021-06-30 | $909.00K | $2.37M | $1.46M | 38.34% |
| 2021-03-31 | (m) | $3.00M | (m) | (m) |
| 2020-12-31 | (m) | $2.33M | (m) | (m) |
| 2020-09-30 | (m) | $1.94M | (m) | (m) |
| 2020-06-30 | (m) | $1.64M | (m) | (m) |
| 2020-03-31 | (m) | $1.31M | (m) | (m) |
| 2019-12-31 | (m) | $1.74M | (m) | (m) |
| 2019-09-30 | (m) | $2.08M | (m) | (m) |
| 2019-06-30 | (m) | $2.02M | (m) | (m) |
| 2019-03-31 | (m) | $1.31M | (m) | (m) |
| 2018-12-31 | (m) | $865.00K | (m) | (m) |
| 2018-09-30 | (m) | $367.00K | (m) | (m) |
| 2018-06-30 | (m) | $444.00K | (m) | (m) |
| 2018-03-31 | (m) | $500.00K | (m) | (m) |
| 2017-12-31 | (m) | $459.00K | (m) | (m) |
| 2017-09-30 | (m) | $381.00K | (m) | (m) |
| 2017-06-30 | (m) | $394.00K | (m) | (m) |
| 2017-03-31 | (m) | $522.00K | (m) | (m) |
| 2016-12-31 | (m) | $864.00K | (m) | (m) |
| 2016-09-30 | (m) | $923.00K | (m) | (m) |
| 2016-06-30 | (m) | $948.00K | (m) | (m) |
| 2016-03-31 | (m) | $989.00K | (m) | (m) |
| 2015-12-31 | (m) | $959.00K | (m) | (m) |
| 2015-09-30 | (m) | $1.19M | (m) | (m) |
| 2015-06-30 | (m) | $1.85M | (m) | (m) |
| 2015-03-31 | (m) | $1.74M | (m) | (m) |
| 2014-12-31 | (m) | $1.39M | (m) | (m) |
| 2014-09-30 | (m) | $1.02M | (m) | (m) |
| 2014-06-30 | (m) | $205.00K | (m) | (m) |
| 2014-03-31 | (m) | $617.00K | (m) | (m) |
| 2013-12-31 | (m) | $617.00K | (m) | (m) |
| 2013-09-30 | (m) | $617.00K | (m) | (m) |
| 2013-06-30 | (m) | $1.01M | (m) | (m) |
| 2013-03-31 | (m) | $741.60K | (m) | (m) |
| 2012-12-31 | (m) | $1.11M | (m) | (m) |
| 2012-09-30 | (m) | $1.35M | (m) | (m) |
| 2012-06-30 | (m) | $1.28M | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $520.08K | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |